// App-Quantinova.ai

TCT-60 : 1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials

Researchers

Presenter

  • Ariel Furer

Principal Investigators

  • Ori Ben-Yehuda

  • Bjorn Redfors

  • Gregg Stone

  • Patrick Serruys

  • Runlin Gao

  • Takeshi Kimura

  • Dean Kereiakes

  • Stephen Ellis

  • weiying zhao

  • Minh-Thien Vu

  • Yoshinobu Onuma

Medical Centers

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

  • Cardiovascular Research Foundation, New York, United States

  • Imperial College, London/Thoraxcenter of Erasmus University, Rotterdam, Netherlands

  • Kyoto University, Kyoto, Japan

  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • The Christ Hospital, Cincinnati, Ohio, United States

  • Fu Wai Hospital, Beijing, Beijing, China

  • Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • CUMC, New York, New York, United States

Locations

  • United States

  • China

  • Japan

  • Netherlands

Companies

  • Abbott

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Renal insufficiency

  • Diabetes

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved